| Primary |
| Diabetes Mellitus |
58.2% |
| Type 1 Diabetes Mellitus |
13.8% |
| Product Used For Unknown Indication |
7.8% |
| Type 2 Diabetes Mellitus |
5.7% |
| Hypertension |
2.6% |
| Diabetes Mellitus Insulin-dependent |
1.8% |
| Hyperglycaemia |
1.3% |
| Pancreatic Disorder |
1.3% |
| Diabetes Mellitus Non-insulin-dependent |
1.0% |
| Iddm |
0.8% |
| Supplementation Therapy |
0.8% |
| Arthritis |
0.5% |
| Bacterial Infection |
0.5% |
| Blood Glucose Increased |
0.5% |
| Cardiogenic Shock |
0.5% |
| Cystitis |
0.5% |
| Depression |
0.5% |
| Dyslipidaemia |
0.5% |
| Gestational Diabetes |
0.5% |
| Hyperkalaemia |
0.5% |
|
| Hypoglycaemia |
40.5% |
| Mental Status Changes |
8.2% |
| Unresponsive To Stimuli |
6.4% |
| Syncope |
5.9% |
| Incorrect Dose Administered |
4.1% |
| Medication Error |
4.1% |
| Treatment Noncompliance |
4.1% |
| Loss Of Consciousness |
3.2% |
| Wrong Drug Administered |
3.2% |
| Vomiting |
2.7% |
| Hypophagia |
2.3% |
| Overdose |
2.3% |
| Road Traffic Accident |
2.3% |
| Diabetic Ketoacidosis |
1.8% |
| Hyperglycaemia |
1.8% |
| Hyperhidrosis |
1.8% |
| Blood Glucose Decreased |
1.4% |
| Drug Exposure During Pregnancy |
1.4% |
| Fall |
1.4% |
| Oral Intake Reduced |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
30.7% |
| Diabetes Mellitus |
15.2% |
| Drug Use For Unknown Indication |
12.5% |
| Type 2 Diabetes Mellitus |
7.6% |
| Drug Abuse |
5.5% |
| Hypertension |
5.5% |
| Overdose |
3.6% |
| Pain |
2.9% |
| Cardiogenic Shock |
2.2% |
| Type 1 Diabetes Mellitus |
2.0% |
| Depression |
1.9% |
| Foetal Exposure During Pregnancy |
1.6% |
| Peritoneal Dialysis |
1.5% |
| Electrolyte Substitution Therapy |
1.3% |
| Gestational Diabetes |
1.1% |
| Cardiac Failure |
1.1% |
| Diabetes Mellitus Insulin-dependent |
1.1% |
| Hyperglycaemia |
1.0% |
| Psoas Abscess |
1.0% |
| Resuscitation |
0.9% |
|
| Hypoglycaemia |
18.4% |
| Completed Suicide |
12.4% |
| Overdose |
7.3% |
| Blood Glucose Increased |
5.5% |
| Toxicity To Various Agents |
5.5% |
| Weight Increased |
5.1% |
| Weight Decreased |
4.9% |
| Blood Glucose Decreased |
4.5% |
| Death |
4.3% |
| Somnolence |
3.3% |
| Glycosylated Haemoglobin Increased |
3.1% |
| Hyperglycaemia |
3.1% |
| Hypokalaemia |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Device Malfunction |
2.9% |
| Poisoning |
2.9% |
| Tremor |
2.9% |
| Respiratory Arrest |
2.7% |
| Suicide Attempt |
2.7% |
| Syncope |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.2% |
| Drug Use For Unknown Indication |
21.0% |
| Diabetes Mellitus |
14.8% |
| Hypertension |
7.6% |
| Type 2 Diabetes Mellitus |
3.5% |
| Rheumatoid Arthritis |
2.5% |
| Pain |
2.4% |
| Depression |
2.3% |
| Prophylaxis |
2.0% |
| Blood Cholesterol Increased |
1.4% |
| Type 1 Diabetes Mellitus |
1.3% |
| Coronary Artery Bypass |
1.3% |
| Osteoporosis |
1.3% |
| Hiv Infection |
1.1% |
| Atrial Fibrillation |
1.1% |
| Peritoneal Dialysis |
1.1% |
| Multiple Myeloma |
1.1% |
| Hepatitis C |
1.0% |
| Asthma |
1.0% |
| Cardiac Disorder |
0.9% |
|
| Vomiting |
12.8% |
| Weight Decreased |
10.6% |
| Myocardial Infarction |
8.9% |
| Blood Glucose Increased |
7.4% |
| Weight Increased |
6.8% |
| Pain |
5.5% |
| Renal Failure |
4.7% |
| Drug Ineffective |
4.5% |
| Death |
4.3% |
| Nausea |
4.2% |
| Renal Failure Acute |
4.0% |
| Sepsis |
3.3% |
| Hypoglycaemia |
3.3% |
| Urinary Tract Infection |
3.2% |
| Pneumonia |
3.0% |
| Cerebrovascular Accident |
3.0% |
| Thrombocytopenia |
2.7% |
| Vision Blurred |
2.7% |
| Tremor |
2.6% |
| Pyrexia |
2.6% |
|
| Interacting |
| Diabetes Mellitus |
20.4% |
| Drug Use For Unknown Indication |
14.3% |
| Product Used For Unknown Indication |
10.2% |
| Hypertension |
9.2% |
| Multiple Sclerosis |
5.1% |
| Pain |
5.1% |
| Type 2 Diabetes Mellitus |
5.1% |
| Cardiac Failure Chronic |
3.1% |
| Cerebral Infarction |
3.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.1% |
| Tenosynovitis |
3.1% |
| Anticoagulant Therapy |
2.0% |
| Antiplatelet Therapy |
2.0% |
| Bacterial Infection |
2.0% |
| Bipolar Disorder |
2.0% |
| Blood Glucose Abnormal |
2.0% |
| Convulsion |
2.0% |
| Diabetic Foot |
2.0% |
| Ischaemic Stroke |
2.0% |
| Type 1 Diabetes Mellitus |
2.0% |
|
| Drug Interaction |
18.2% |
| Hyperglycaemia |
9.1% |
| Surgery |
9.1% |
| Tremor |
9.1% |
| Hyperhidrosis |
6.1% |
| Hypoglycaemia |
6.1% |
| Blood Glucose Decreased |
3.0% |
| Condition Aggravated |
3.0% |
| Confusional State |
3.0% |
| Drug Hypersensitivity |
3.0% |
| Dysgeusia |
3.0% |
| Flatulence |
3.0% |
| Gastric Disorder |
3.0% |
| Jaundice |
3.0% |
| Oedema |
3.0% |
| Overdose |
3.0% |
| Palpitations |
3.0% |
| Peripheral Artery Thrombosis |
3.0% |
| Petit Mal Epilepsy |
3.0% |
| Sinus Bradycardia |
3.0% |
|
